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ABSTRACT 
Background The shear stress distribution assessment can provide useful insights for the hemodynamic 
performance of the implanted stent/scaffold. Our aim was to investigate the effect of a novel bioresorbable 
scaffold, Mirage on local hemodynamics in animal models. 
Method The main epicardial coronary arteries of 7 healthy mini-pigs were implanted with 11 Mirage 
Microfiber sirolimus-eluting Bioresorbable Scaffolds (MMSES). Optical coherence tomography (OCT) was 
performed post scaffold implantation and the obtained images were fused with angiographic data to 
reconstruct the coronary artery anatomy. Blood flow simulation was performed and Endothelial Shear Stress 
(ESS) distribution was estimated for each of the 11 scaffolds. ESS data were extracted in each circumferential 
5-degree subunit of each cross-section in the scaffolded segment. The generalized linear mixed-effect 
analysis was implemented for the comparison of ESS in two scaffold groups; 150-µm strut thickness MMSES 
and 125-µm strut thickness MMSES. 
Results ESS was significantly higher in MMSES (150 µm) [0.85(0.49–1.40) Pa], compared to MMSES (125 µm) 
[0.68(0.35–1.18) Pa]. Both MMSES (150 µm) and MMSES (125 µm) revealed low recirculation zone 
percentages per luminal surface area [3.17% ± 1.97% in MMSES (150 µm), 2.71% ± 1.32% in MMSES (125 
µm)]. 
Conclusion Thinner strut Mirage scaffolds induced lower shear stress due to the small size vessels treated as 
compared to the thick strut version of the Mirage which was implanted in relatively bigger size vessels. 
Vessel size should be taken into account in planning BRS implantation. Small vessels may not get benefit 
from BRS implantation even with a streamlined strut profile. This pilot study warrants comparative 
assessment with commercially available bioresorbable scaffolds.  
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1. INTRODUCTION 
Metallic drug eluting stents have significant limitations including the risks of neoatherosclerosis, late stent 
thrombosis, and restenosis which affect long term prognosis. Bioresorbable scaffolds (BRS) have been 
introduced to overcome these issues with potential benefits of allowing future treatments, non-invasive 
imaging procedures and recovering vessel physiology during bioresorption process of the scaffold. Despite 
its theoretical benefits, recent reports of neoatherosclerosis and scaffold thrombosis have emerged 
concerns about the designs of BRS [1]. Thicker struts, bulky structure, non-streamlined strut geometry and 
early mechanical disruption have been charged for underlying pathological mechanisms. Local coronary 
hemodynamics, particularly endothelial shear stress (ESS) seems to drive these mechanisms [2]. Following 
stent/scaffold implantation, the device geometry, strut profile, and curvature status of the implanted vessel 
segment influence the rheological behavior of the scaffolded segment [3]. The in vivo evaluation of the 
impact of protruding struts on local hemodynamic patterns in the current available BRS has revealed the 
interaction between shifted ESS and the intimal tissue response [4]. 
Mirage microfiber sirolimus-eluting bioresorbable scaffold (MMSES, Manli Cardiology, Singapore) is a novel 
coronary stent that has substantial differences in geometrical design, strut profile, strut thickness, and strut 
connector alignments. The objective of this preclinical study was to determine the flow characteristics and 
ESS distribution in MMSES implanted coronary artery segments. 
 
2. METHODS 
We analyzed data from Yucatan mini-pigs implanted with MMSES. Seven mini-pigs with healthy coronaries 
underwent percutaneous coronary intervention (PCI) in select epicardial coronary arteries via the femoral 
access according to standard procedures. Six coronaries were implanted with a single MMSES with 150-µm 
strut thickness [MMSES(150 µm)] and five coronaries with a MMSES with 125-µm strut thickness [MMSES 
(125 µm)]. The treated coronary arteries were imaged by OCT immediately after the scaffold implantation. 
The protocol approval for the animal study was received from the Institutional Animal Care and Use 
Committee and the study was conducted in accordance to the American Heart Association guidelines for 
preclinical research and the Guide for the Care and Use of Laboratory Animals [5]. 
 
2.1 Scaffold design 
Mirage scaffold is produced from poly-d-l-lactide (PDLLA) of which d(dextro-rotary)-isomer constitutes <5% 
of the total polylactic acid (PLA), coated with a biodegradable PLA eluting sirolimus. MMSES is manufactured 
by winding the polylactide monofilaments into helix-coiled structure. The struts have circular profile with 
thickness of 125 µm in scaffolds with diameter ≤3mm, and 150 µm in scaffolds with diameter ≥3.5 mm 
(Figure 1). The scaffold design consists of a helicoidal coil structure in which the monofilament maintains its 
directional mechanical properties as well as its circular geometry (Figure 2A). When compared to the 
benchmark Absorb scaffold (27%), Mirage scaffold has 45% vessel luminal coverage ratio [6]. The helical-coil 
design is fastened by longitudinal spine microfibers providing radial strength for the MMSES (150 µm) 
(148.54 kPa) and MMSES (125 µm) (120.54 kPa) comparable to the current available BRS [7]. MMSES (125 
µm) and MMSES (150 µm) have a tensile strength of 300 MPa with an elongation at break of 35% 
(information from the manufacturer). In addition, in vitro and in vivo degradation profile has confirmed that 
the Mirage polylactide is basically fully biodegraded after 14 months (Figure 2B). 
 
3 
 
2.2 Data acquisition 
X-ray angiography was performed using Siemens HiCor cardiac angiography system (Siemens, Erlangen, 
Germany). OCT was performed following scaffold implantation in all the coronary arteries implanted with 
bioresorbable scaffolds. The treated segments were studied using a frequency-domain OCT system (C8-XR 
OCT Intravascular Imaging System; St. Jude Medical, St. Paul, MN) that was pulled-back at a speed of 18 mm 
sec−1. A nonocclusive flushing technique was used for blood clearance by injection of contrast media. The 
acquired data were stored in DICOM format and transferred to a workstation for further analysis. 
 
2.3 Coronary artery reconstruction 
Coronary artery reconstruction was performed using a well-established and validated methodology [8]. In 
brief the angiographic and OCT data were reviewed to identify the scaffolded segment and the most 
proximal and distal anatomical landmarks (i.e. side branches) to the scaffolded segment, that were visible in 
both coronary angiography and OCT. These landmarks were used to define the segment of interest, that was 
reconstructed from OCT and X-ray angiographic data for computational fluid dynamic (CFD) model [8]. 
In the segment of interest, an observer identified the OCT images portraying the scaffolded and the native 
coronary artery and analyzed the OCT frames at every 0.1 mm interval in the scaffolded segment and at 
every 0.2 mm interval in the native vessel. In the native and the scaffolded segment the observer delineated 
the flow area—defined in the native segment by the lumen border and in the scaffolded segment by the 
adluminal side of the struts and by the lumen surface in the areas between the struts [9]. 
Two post-procedure end-diastolic X-ray angiographic images with at least >30° angle difference portraying 
the segment of interest with minimal foreshortening were selected with the table in the isocenter. In these 
images the lumen borders were detected for the segment of interest and used to extract the luminal 
centerline that was then used to define the 3D luminal centerline of the segment of interest [8]. The borders 
detected in the OCT images were then placed perpendicularly onto the luminal centerline and anatomical 
landmarks, that were side-branches seen in both OCT and X-ray images were used to define the absolute 
orientation of the OCT frames [8]. 
 
2.4 Blood flow simulation 
The reconstructed images were processed with CFD techniques. A finite volume mesh was generated and 
then blood flow simulation was performed and the ESS was estimated by solving the 3D Navier-Stokes 
equations (ANSYS Fluent, Canonsburg, Pennsylvania) [10]. To assess the effect of the scaffold designs on the 
local hemodynamic micro-environment, the mesh density around the scaffold struts and within the 
boundary layer of the flow field between the struts was increased to have an average element edge of 30 
μm (equal to ¼ of the strut thickness of the scaffold strut). Blood was assumed to be a homogeneous, 
Newtonian fluid with a viscosity of 0.0035 Pa s−1 and a density of 1,050 kg m−3. A steady flow profile was 
simulated at the inflow of the 3D models. Previously, publications showed that there are no significant 
differences between the ESS estimated in pulsatile and steady flow simulations [11, 12]. Blood flow for each 
reconstruction was estimated by measuring, in the two angiographic projections, the number of frames 
required for the contrast agent to pass from the inlet to the outlet of the reconstructed segment, the volume 
of the reconstructed segment and the cine frame rate [2, 13]. The arterial wall was considered to be rigid. 
No-slip conditions were imposed at the scaffold surface. At the outlet of the model zero pressure conditions 
were imposed. ESS at the baseline luminal surface was calculated as the product of blood viscosity and the 
gradient of blood velocity at the wall [14]. The ESS was measured in the native and the scaffolded segment 
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around the circumference of the lumen per 5° interval (sector) and along the axial direction per 0.2-mm 
interval with the use of an in-house algorithm [4] (Figure 3). The recirculation zones in the vicinity of the 
struts were quantified based on the direction of the ESS vector and the centerline vector. Areas where the 
ESS vector had opposite direction to the centerline vector were considered to be exposed to recirculation 
zones (Figure 4). 
 
2.5 Statistical analysis 
Continuous variables were tested for normality with Kolmogorov-Smirnov test and are presented as 
mean ± SD or median (interquartile range) as appropriate. Categorical variables are presented as counts and 
percentages. Mixed linear model with an assumed Gaussian distribution was used for the comparisons of 
continuous variables to take into account the clustered nature of >1 scaffolds analyzed from the same 
animals and >1 cross-sections from the same scaffold and >1 5°-sectors from the same cross-sections, that 
should be in correlations within the clusters. Pearson correlation coefficients were used to evaluate the 
strength and direction of the linear relationship between the strut thickness, cross-section area and ESS. 
Statistical significance was assumed at a probability (P) value of <0.05. All statistical analyses were 
performed with SPSS (version 22.0.0, IBM, New York). 
 
3. RESULTS 
In MMSES (150 µm) group (n = 6 arteries), 2 LAD, 1 LCX and 3 RCA, in MMSES (125 µm) group (n = 5 arteries) 
2 LAD, 1 LCX and 2 RCA were treated. The list of scaffolds with diameters, lengths, deployment pressures, 
post-implantation dilatation balloon pressures, post-implantation scaffolded vessel segment diameters and 
the treated coronaries with the implantation locations are shown in Table 1. The dimensions of the proximal 
segment, scaffolded segment and the distal segment are shown in Table 2 and Supporting Information Table 
1. 
The median ESS of MMSES (150 µm) and MMSES (125 µm) are 0.85 (IQ:0.49–1.39) and 0.68 (IQ:0.35–1.18), 
respectively. The histograms of ESS for the MMSES (150 µm) and MMSES (125µm) (Figure 5) show that, 58% 
of the scaffolded vessel luminal surface in the MMSES (150 µm) and 66% MMSES (125 µm) was exposed to a 
low (<1 Pa) athero-promoting ESS environment (Figure 6) (Table 3). This paradoxical results should stem 
from the fact that the MMSES (125 µm) was implanted in small size (<3.0 mm) vessels while the MMSES (150 
µm) was implanted in bigger size (>3.5 mm) vessels; when the strut thickness was divided to final lumen 
diameter after the implantation the mean ratio in MMSES (125 µm) was 0.020 and in MMSES (150 µm) was 
0.017. The percentages of recirculation area per scaffolded vessel segment surface area were 3.17% ± 1.97% 
in MMSES (150 µm) and 2.71% ± 1.32% in MMSES (125 µm). At device level, there was no statistical 
difference between the scaffold groups for recirculation area (P = 0.91) (Table 4). ESS had a negative 
correlation with strut thickness (r = −0.17, P < 0.0001). The strut thickness had significant correlation with the 
recirculation zone area per luminal surface area (r = 0.555, P < 0.0001). 
 
4. DISCUSSION 
In this exploratory study, we evaluated Mirage scaffold with two strut thicknesses in porcine coronary artery 
models. The findings were as follows: (1) The thinner strut version Mirage scaffold [MMSES (125 µm)] was 
implanted in smaller vessels (<3.0 mm) while thick strut version Mirage [MMSES(150 µm)] was implanted in 
bigger size (>3.5 mm) vessels which induced lower ESS in MMSES (125 µm) than in MMSES (150 µm) and due 
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to the same fact, (2) The percent luminal surface exposed to lower-ESS (<1.0 Pa) was higher in MMSES (125 
µm) as compared to MMSES (150 µm). (3) Scaffolded segments revealed minimal recirculation zones per 
scaffolded luminal surface. However, due to device level comparison, there was no significant difference for 
recirculation area percentages between MMSES (150 µm) and MMSES (125 µm) underscoring the role that 
the artery size plays in the regional hemodynamic effects of the scaffold placement. 
Several in silico studies have mentioned the effect of stent design on local hemodynamics after device 
implantation. Mirage scaffold has a unique helicoidal design with thinner strut thicknesses. The circular strut 
profile gives an advantage to Mirage scaffold inducing potentially less flow disruption [3]. The streamlined 
strut profile exhibited minimal recirculation areas and less shifted ESS distributions in this novel scaffold 
[15]. The helicoidal design provides less flow disruption and recirculation areas compared to the corrugated 
ring design [15, 16]. Mirage scaffold has 45% vessel luminal coverage ratio which can also help to explain low 
percentage of recirculation areas per luminal surface in scaffolded segments. The high coverage ratio with 
streamlined strut profile should have enabled the flow streamlines be in an aligned structure within the 
scaffolded segments. The increased luminal surface coverage decreases the risk of the interaction between 
disrupted flow and denuded endothelial layer that prevents the activation of pathological cellular 
mechanisms for tissue response and thrombus formation. In Mirage scaffold, the maximal coil pitch between 
the helicoidal rings is 0.8 mm which is enough for an inter-strut space to recover a smooth flow after 
disruption in the vicinity of the struts [17, 18]. Helicoidal design, thinner circular strut, increased luminal 
surface coverage and an adequate maximal coil pitch are the contributing factors for relatively low flow 
disruption in the scaffolded vessel segments [15]. In vitro experimental studies have demonstrated that the 
different strut designs have different influences on the local flow behavior. Strut thickness, strut shape and 
material properties have impact on the local flow. While strut thickness increases, the flow disruption 
around the strut increases [19]. Not only the strut thickness, but also the strut cross-profile has impact on 
flow disruption. The effect of strut thickness on the flow disruption in streamlined and non-streamlined strut 
profiles is not the same; as the thickness increases in a non-streamlined strut design, the flow disturbance 
demonstrates a nonlinear increment. Regarding the increase in flow disruption, experiments have 
demonstrated a rise in the fibrin accumulation around the struts. In the same line with these experimental 
studies, we have reported the effect of square-shaped struts on the local flow dynamics using similar porcine 
model and similar methodology for the flow simulation and shear stress analysis. In our previous study [15, 
20], in Absorb implanted segments median shear stress level was 0.57 ([IQR]: 0.29–0.99) Pa. In Absorb 
implanted segments, 75% of the scaffolded surface was exposed to a low (< 1 Pa) athero-promoting ESS and 
the percentage of recirculation area was 3.26% ± 2.07%. Using similar animal model and CFD methodology, 
in the present study, median ESS of MMSES (150 µm) and MMSES (125 µm) were 0.85(IQ:0.49–1.39) Pa and 
0.68 (IQ:0.35–1.18) Pa which were quite higher than Absorb in our previous study [15]. Regarding low ESS, 
58% of the scaffolded vessel luminal surface in MMSES (150 µm) and 66% in MMSES (125 µm) were exposed 
to low (<1 Pa) ESS those were quite lower than in Absorb (75%). The percentages of recirculation area per 
scaffolded vessel surface area were 3.17% ± 1.97% in MMSES (150 µm) and 2.71% ± 1.32% in MMSES (125 
µm) which were lower than in Absorb (3.26% ± 2.07%). 
In many experimental CFD analyses, thinner streamlined struts were in favor of flow hemodynamics, 
inducing less flow separation and less recirculation zones in the vicinity of the struts (3). In our exploratory 
study, the ESS values were paradoxically lower in MMSES (125 µm) than in MMSES (150 µm). The main 
factor to explain this paradoxical result is the fact that as realized in Table 2 the final diameter of the vessels 
in Mirage (150 µm) was higher (mean 3.75 mm) than in Mirage (125 µm) (mean 3.04 mm) following the 
implantation. When the strut thickness is divided to the final luminal diameters in scaffolded vessel 
segments after implantation, it will be realized that the ratio of strut thickness/final lumen size is lower (strut 
thickness/final lumen diameter = 0.017) in Mirage (150 µm) than in Mirage (125 µm) (strut thickness/final 
lumen diameter = 0.020). It's obvious that the scaffolds with thinner struts [Mirage (125 µm)] were 
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implanted in smaller vessels (<3.0 mm) whereas thick strut version of Mirage [Mirage (150 µm)] was 
implanted in bigger size vessels (>3.5 mm). However, in smaller vessels, even thinner struts induced lower 
ESS which denotes the fact that in small vessels the deteriorating effect of the struts are not avoidable 
despite thinner design. It seems that even with thin strut thicknesses, the small vessels may not benefit from 
BRS implantation. Because of this point, in correlation with mean ESS values, we found lower surface area 
exposed to <1 Pa ESS in Mirage (150 µm) rather than in Mirage (125 µm). These results showed that during 
planning stage of the PCI, scaffold strut thickness/vessel size diameter ratio should be taken into account to 
decrease fluctuations in ESS post-implantation. Another contributing factor for paradoxical result might be 
due to the Coanda effect; the flow is accelerating over the convex surfaces and in thicker circular struts this 
effect increases along with the elevated shear stress levels on the top surface of the struts [21]. As the 
thicker struts get in touch with the faster flowing flow zones in the radial direction within the vessel lumen, it 
results in higher shear stress levels at the top surface of the struts which also contributed higher levels of ESS 
in Mirage (150 µm) compared to Mirage (125 µm) (Supporting Information).” 
4.1 Limitations 
The current results require interpretation within the constraints of some limitations. First, scaffold 
implantation was performed in healthy coronary arteries. Therefore, it was not possible to examine the 
implications of scaffold under-expansion or the composition of the underlying plaque on strut embedment 
which potentially influence the local flow hemodynamics. Second, there was no comparator which would 
enable to make a hypothesis for the “hemo-compatible” properties of Mirage bioresorbable scaffold. 
 
5. CONCLUSION 
Mirage scaffold has unique properties of helicoidal design, thinner struts—compared to current commercial 
available scaffolds—and streamlined strut profile. However, thinner strut version of Mirage induced lower 
ESS than thick strut version due to the higher ratio of strut thickness/lumen area in Mirage (125 µm). The 
size of the target vessel segment should be assessed before the implantation of Mirage scaffold and small 
vessels should not be implanted with Mirage. The CFD study can be used to increase the hemo-compatibility 
of the bioresorbable scaffolds. The results should prompt further comparative study with the commercially 
available scaffolds in animal and human models. 
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Table 1. Inventory of scaffolds with strut thicknesses and implantation parameters. 
Scaffold Animal Vessel 
Saffolded 
vessel 
segment 
Scaffold 
size (mm) 
Deployment 
balloon 
pressure (atm) 
Post-dilatation 
balloon 
inflation 
pressure (atm) 
The scaffolded 
vessel segment 
diameter after 
implantation 
(mm) 
MMSES-
1(125 µm) 
Animal-E LCx Mid 2.75 × 13 6 16 3.0 
MMSES-
2(125 µm) 
Animal-F LAD Prox 2.75 × 13 16 18 3.0 
MMSES-
3(150 µm) 
Animal-D LCx Mid 3.50 × 15 6 14 3.7 
MMSES-
4(150 µm) 
Animal-D RCA Mid 3.50 × 15 6 16 3.7 
MMSES-
5(125 µm) 
Animal-E LAD Mid 2.50 × 15 6 16 2.6 
MMSES-
6(150 µm) 
Animal-C LAD Prox 3.50 × 15 6 16 3.7 
MMSES-
7(150 µm) 
Animal-G RCA Mid 3.50 × 15 6 14 3.8 
MMSES-
8(125 µm) 
Animal-A RCA Mid 3.00 × 15 12 20 3.3 
MMSES-
9(125 µm) 
Animal-F RCA Mid 3.00 × 15 10 18 3.3 
MMSES-
10(150 µm) 
Animal-B RCA Mid 3.50 × 15 18 18 3.8 
MMSES-
11(150 µm) 
Animal-A LAD Prox 3.50 × 15 16 18 3.8 
 
 
Table 2. The OCT analyzes of scaffolded and non-scaffolded segments according to the scaffold type (device 
level) 
 MMSES (150 µm) (n = 6) MMSES (125 µm) (n = 5) 
Scaffolded segment lumen area (mm2) 8.65 (4.50–12.80) 6.35 (3.49–9.21) 
Distal non-scaffolded segment lumen area (mm2) 7.67 (5.85–9.42) 5.14 (2.01–8.27) 
Proximal non-scaffolded segment lumen area 
(mm2) 
7.67 (5.85–9.49) 5.58 (4.69–6.47) 
Strut area (mm2) 0.88 (0.60–1.16) 0.63 (0.22–1.04) 
 
The results are as Median (Quartile 1-Quartile 3). 
  
10 
 
Table 3. The median ESS of the scaffold groups in 5°-sectorial subunit level. 
 MMSES (150 µ) (n = 31,176) 
Median (Q1–Q3) 
MMSES (125 µ) (n = 22,248) 
Median (Q1–Q3) 
ESS [Pa] (5°-sectorial subunit level) 0.85 (0.49–1.39) 0.68(0.35–1.18)* 
ESS ≤ 1.0 Pa (%) 57.7 66.4# 
 
* Significant difference between MMSES (150 µm) and MMSES (125 µm); P < 0.00001. 
# Significant difference between MMSES (150 µm) and MMSES (125 µm); P < 0.00001. 
P values derived from a multilevel linear regression model that adjusted ESS values for vessel type and 
scaffold cross-sectional area, given the clustered nature of the data. 
 
Table 4. Recirculation area per scaffolded vessel surface area percentages in scaffold groups. 
Scaffold Recirculation area per scaffolded vessel surface area (%) Mean ± SD 
MMSES-3 (150 µm) 5.81  
MMSES-4 (150 µm) 1.35   
MMSES-6 (150 µm) 1.60  2.71 ± 1.32* 
MMSES-7 (150 µm) 3.98   
MMSES-10 (150 µm) 1.40   
MMSES-11 (150 µm) 4.88   
MMSES-1 (125 µm) 2.00  
MMSES-2 (125 µm) 2.81   
MMSES-5 (125 µm) 0.87 3.17 ± 1.97 
MMSES-8 (125 µm) 3.93   
MMSES-9 (125 µm) 3.98   
 
* Comparison between MMSES (150 µm) and MMSES (125 µm), P = 0.91 
 
 
 
Figure 1. OCT cross-section image of Mirage scaffold. The strut of the Mirage scaffold is circular and non-
translucent.  
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Figure 2. (A) Manli cardiology's microfiber technology. Highly oriented polylactide polymer is extruded and 
annealed to form a circular monofilament with preferred directional mechanical properties (A, B). 
Conversion of a circular monofilament into a helicoidal scaffold with circular strut geometry. Coil design 
enables scaffold to inherit monofilament's directional mechanical properties and monofilament's circular 
geometry (C, D). Three longitudinal spines are attached at ambient temperature to guarantee the 
mechanical stability of the helicoidal structures (D).(Produced with permission from JACC Int). (B) Mirage 
scaffold degradation and radial strength profile. In vitro and in vivo degradation profile in comparison with 
the BVS has confirmed that the Mirage polylactide is basically fully biodegraded after 14 months (A). Mirage 
scaffold with strut thickness of 125 micron has a tensile strength of 300 MPa with an elongation at break of 
35% and a radial strength of 120 kPa,—very comparable to the radial strength of the Xience V for a strut 
thickness of 81 micron (B). (Produced with permission from JACC Int) 
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Figure 3. Circumferential ESS values (median, maximum and minimum) over the luminal perimeter at 5°-
subunits (sectors) counted from 3 o'clock. 
 
 
 
Figure 4. Recirculation zones(red) were quantified based on the ESS and the centerline direction (proximal 
→ distal). The red areas in the luminal surface are where the vectors of the ESS are pointing opposite (more 
than 90-degrees away from) the proximal-to-distal direction along the centerline. 
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Figure 5. Histograms of ESS in scaffolded segments in scaffold groups. “n” denotes the number of total ESS 
estimations at 5°-sectorial level. 
 
 
Figure 6. Three-dimensional reconstruction of scaffolded coronary anatomy from the fusion of coronary 
angiograms and OCT data with the local ESS being portrayed in a color-coded map (dark blue indicates low 
ESS < 1.0 Pa and aquamarine an ESS ≥1.0 Pa) for Mirage scaffold (A and B).
14 
 
 
 
 
Supplementary Table 1: The median ESS and lumen area in OCT in scaffolded and non-scaffolded segment in OCT for each scaffold. The data are tabulated 
according to the ranking of ESS in Mirage bioresorbable scaffold. 
Scaffold Animal Median ESS (Q1-Q3)- 
Scaffolded segment 
(Pa) 
Median Lumen Area (Q1-Q3)- 
Scaffolded segment (mm2) 
Median Lumen area (Q1-Q3)- 
Distal non-scaffolded segment 
(mm2) 
Median Lumen area (Q1-Q3)- 
Proximal non-scaffolded 
segment (mm2) 
MMSES-1 (125 µm) E 0.48 (0.27-0.76) 7.02 (6.88-7.11) 4.37 (4.26-4.47) 4.58 (4.21-4.72) 
MMSES-2 (125 µm)  F 0.48 (0.24-0.87) 8.98 (8.29-9.81) 7.40 (4.59-7.95) 5.75 (5.59-6.12) 
MMSES-3 (150 µm) D 0.56 (0.35-0.86) 10.94 (10.56-11.45) 6.90 (6.21-7.46) 7.67 (6.38-8.77) 
MMSES-4 (150 µm)  D 0.62 (0.29-1.04) 5.78 (5.66-5.92) 5.14 (4.50-5.69) 5.79 (3.94-8.52) 
MMSES-5 (125 µm)  E 0.63 (0.35-1.04) 11.21 (10.92-11.40) 8.71 (8.25-9.14) 6.14 (5.06-7.91) 
MMSES-6 (150 µm)  C 0.92 (0.56-1.35) 12.59 (12.49-12.74) 10.94 (10.33-11.48) 9.84 (9.49-10.81) 
MMSES-7 (150 µm)  G 0.94 (0.52-1.51) 7.13 (7.08-7.35) 7.80 (7.42-7.95) 5.58 (5.45-5.81) 
MMSES-8 (125 µm)  A 0.94 (0.53-1.56) 7.25 (7.04-7.78) 4.57 (4.39-7.05) 5.18 (4.74-5.44) 
MMSES-9 (125 µm) F 0.96 (0.50-1.60) 10.87 (10.68-11.21) 7.25 (7.02-7.50) 7.67 (7.42-9.09) 
MMSES-10 (150 µm) B 1.00 (0.67-1.39) 9.74 (9.44-10.18) 6.34 (6.18-6.98) 7.59 (7.22-7.52) 
MMSES-11 (150 µm) A 1.44 (0.86-1.86) 10.47 (10.13-10.95) 6.29 (4.60-7.85) 8.78 (8.56-9.20) 
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Supplementary Figure 1. Flow streamlines and associated ESS for representative cases of Mirage (150 µm) and Mirage (125 µm). 
